Melatonin Supplementation as Adjuvant Therapy for the Prevention of Bronchopulmonary Dysplasia in Neonates
Background: Neonatal bronchopulmonary dysplasia (BPD) is a chronic chest disease caused by prolonged ventilation and oxygenation which leads to neonatal disability.<br />Methods: It was a prospective randomized clinical trial (RCT) (Study ID: TCTR20191211004) which was conducted in Tanta Unive...
Main Authors: | Mohamed Shawky Elfarargy, Dina Adam Ali, Ghada Mohammad Al-Ashmawy |
---|---|
Format: | Article |
Language: | English |
Published: |
Mashhad University of Medical Sciences
2020-05-01
|
Series: | Iranian Journal of Neonatology |
Subjects: | |
Online Access: | http://ijn.mums.ac.ir/article_14725_8c0d5ba3e7dfaf5aff6d0e1cc8c1c74b.pdf |
Similar Items
-
An Update on the Prevention and Management of Bronchopulmonary Dysplasia
by: Hennelly M, et al.
Published: (2021-08-01) -
Treatment and prophylaxis of moderate and severe bronchopulmonary dysplasia in premature neonates
by: A.V. Bolonska, et al.
Published: (2021-09-01) -
Fluid and electrolyte balance during the first week of life and risk of bronchopulmonary dysplasia in the preterm neonate
by: Gustavo Rocha, et al.
Published: (2010-01-01) -
Pharmacotherapy in Bronchopulmonary Dysplasia: What Is the Evidence?
by: Rishika P. Sakaria, et al.
Published: (2022-03-01) -
Progressive Metabolic Abnormalities Associated with the Development of Neonatal Bronchopulmonary Dysplasia
by: Chengyin Ye, et al.
Published: (2022-08-01)